Evaluation of the anticarcinogenic effect of Kefir in Drosophila melanogaster
DOI:
https://doi.org/10.33448/rsd-v11i15.33972Keywords:
Cancer; Drosophila melanogaster; Kefir.Abstract
Introduction: The estimate of new cases of cancer by the National Cancer Institute (INCA), in 2020, was more than 620 thousand cases and the important association between neoplasms and lifestyle should be considered. Kefir has been gaining ground due to its properties, including its anti-cancer action. Objective: To evaluate the anticarcinogenic effect of kefir on Drosophila melanogaster cells. Methodology: Kefir was tested by means of the Epithelial Tumor Test (ETT) in D. melanogaster. Females of the wts lineage and males of the mwh lineage were crossed. The offspring larvae were treated with three concentrations of kefir: 1.25mg/mL; 2.5mg/mL and 5.0mg/mL alone and in association with the chemotherapy drug doxorubicin (DXR). Results and discussion: Kefir was not carcinogenic at any of the concentrations tested and had an anticarcinogenic effect at the three concentrations tested. Final considerations: The study suggests a beneficial effect of kefir in cancer prevention and treatment.
References
Azizi, N. F., Kumar, M. R., Yeap, S. K., Abdullah, J. O., Khalid, M., Omar, A. R.; Osman, M. A., Mortadza, S. A. S., & Alitheen, N. B. (2021) Kefir and Its Biological Activities. Foods, 10, (6)1210. 10.3390/foods10061210.
Baschali, A., Tsakalidou, E., Kyriacou, A., Karavasiloglou, N., & Matalas, A. L. (2017). Traditional low-alcoholic and non-alcoholic fermented beverages consumed in European countries: a neglected food group. Nutrition Research Reviews, 30, (1)1-24. 10.1017/s0954422416000202.
Bourrie, B. C. T.; Willing, B. P.; & Cotter, P. D. (2016). The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir. Frontiers In Microbiology, 7, 1-17. 10.3389/fmicb.2016.00647
BRASIL. (2020). Estimate 2020: cancer incidence in Brazil (Estimativa 2018: incidência de câncer no Brasil). National Cancer Institute (Instituto Nacional de Câncer -INCA). Rio de Janeiro: INCA.
Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., & Jemal A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68, (6)394-424. 10.3322/caac.21492.
Carasi P., Racedo S.M., Jacquot C., Romanin D.E., Serradell M.A., & Urdaci M.C. (2015). Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. J Immunol Res, 2015, 1-12. 10.1155/2015/361604.
Chen C., Chan H.M., & Kubow S. (2007). Kefir extracts suppress in vitro proliferation of estrogen-dependent human breast cancer cells but not normal mammary epithelial cells. J Med Food, 10, (3):416-22. 10.1089/jmf.2006.236.
Zhina C., Junling S., Xijuan Y., Bo N., Yang L., & Zhongfu W. (2015). Chemical and physical characteristics and antioxidant activities of the exopolysaccharide produced by Tibetan kefir grains during milk fermentation. International Dairy Journal, 43, 15-21. 10.1016/j.idairyj.2014.10.004.
Eeken J.C., Klink I., van Veen B.L., Pastink A., & Ferro W. (2002). Induction of epithelial tumors in Drosophila melanogaster heterozygous for the tumor suppressor gene wts. Environ Mol Mutagen, 40, (4)277-82. 10.1002/em.10119.
FAULDOXO®: cloridrato de doxorrubicina. Farmacêutica Responsável: Cintia Delphino de Andrade. São Paulo: Libbs Farmacêutica Ltda, 2017. Bula de Remédio.
Farnworth, E. R. (2005). Kefir: a complex probiotic. Food Science: Functional Foods, 2, (1)1-17. 10.1616/1476-2137.13938.
Fernandes M. S., Sanches L. F., Rodrigues D., Handa C., Guelfi M., & Garcia S. (2017). Ida EI. Evaluation of the isoflavone and total phenolic contents of kefir-fermented soymilk storage and after the in vitro digestive system simulation. Food Chem, 15, (29)373-380. 10.1016/j.foodchem.2017.02.095.
Fiorda F.A., Melo P. G.V., Thomaz-Soccol V., Rakshit S.K., Pagnoncelli M.G.B., & Vandenberghe L.P.S. (2017). Soccol CR. Microbiological, biochemical, and functional aspects of sugary kefir fermentation - A review. Food Microbiol, 66, 86-95. 10.1016/j.fm.2017.04.004.
KEFIR: liofilizado. Farmacêutico responsável: Fagner Martimiano. Ipanema: Farmácia Cruz e Costa Ltda, 2022. Bula de Remédio.
Jalali, F., Sharifi, M., & Salehi, R. (2015). Kefir induces apoptosis and inhibits cell proliferation in human acute erythroleukemia. Medical Oncology, 33, (1)7. 10.1007/s12032-015-0722-8
Kerschbaum E., & Nüssler V. (2019). Cancer Prevention with Nutrition and Lifestyle. Visc Med, 35, (4)204-209. 10.1159/000501776.
LeBlanc A. M., Matar C., Farnworth E., & Perdigon G. (2006). Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine, 34, (1-2)1-8. 10.1016/j.cyto.2006.03.008.
Leblanc A. M., Matar C., Farnworth E., & Perdigón G. (2007). Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model. J Dairy Sci, 90, (4)1920-8. 10.3168/jds.2006-079
Liu J.R., Wang S.Y., Lin Y.Y., & Lin C.W. (2002). Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutr Cancer, 44, (2)183-7. 10.1207/S15327914NC4402_10
Murphy N., Moreno V., Hughes D.J., Vodicka L., Vodicka P., Aglago E.K., Gunter M.J., & Jenab M. (2019). Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med, 69, 2-9. 10.1016/j.mam.2019.06.005
Prado, M. R., Blandón, L. M., Vandenberghe, L. P. S., Rodrigues, C., Castro, G. R., Thomaz-Soccol, V., & Soccol, C. R. (2015). Milk kefir: composition, microbial cultures, biological activities, and related products. Frontiers In Microbiology, 6, 1177. doi10.3389/fmicb.2015.01177.
Rafie N, Golpour H. S., Ghiasvand R., & Miraghajani M. (2015). Kefir and Cancer: A Systematic Review of Literatures. Arch Iran Med, 18, (12)852-7. PMID: 26621019
Rosa D.D., Dias M.M.S., Grześkowiak Ł.M., Reis S.A., Conceição L.L., & Peluzio M.D.C.G. (2017). Milk kefir: nutritional, microbiological and health benefits. Nutr Res Ver, 30, (1)82-96. 10.1017/S0954422416000275
Salminen S., Bouley C., Boutron-Ruault M.C., Cummings J.H., Franck A., Gibson G.R., Isolauri E., Moreau M.C., Roberfroid M., & Rowland I. (1998). Functional food science and gastrointestinal physiology and function. Br J Nutr, 80, (1)S147-71. 10.1079/bjn19980108
Santos, F. L. Kefir: propriedades funcionais e gastronômicas. (2015). Cruz das Almas- Bahia: Editora UFRB, 124.
Sharifi M., Moridnia A., Mortazavi D., Salehi M., Bagheri M., & Sheikhi A. (2017). Kefir: a powerful probiotics with anticancer properties. Med Oncol, 34, (11)183. 10.1007/s12032-017-1044-9
Silva M.J.S., O'Dwyer G., & Osorio-de-Castro C.G.S. (2019). Cancer care in Brazil: structure and geographical distribution. BMC Cancer, 19, (1)987. 10.1186/s12885-019-6190-3
Slattery C., Cotter P.D., & O'Toole P.W. (2019). Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir. Nutrients, 11, (6)1252. 10.3390/nu11061252
Gemechu, T. (2015). Review on lactic acid bacteria function in milk fermentation and preservation. African Journal of Food Science, 9, (4)170-175. 10.5897/AJFS2015.1276
Vasconcelos M.A., Orsolin P.C., Silva-Oliveira R.G., Nepomuceno J.C., & Spanó M.A. (2017). Assessment of the carcinogenic potential of high intense-sweeteners through the test for detection of epithelial tumor clones (warts) in Drosophila melanogaster. Food Chem Toxicol, 101, 1-7. 10.1016/j.fct.2016.12.028
Vinderola G., Perdigón G., Duarte J., Farnworth E., & Matar C. (2006). Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine, 36, (5-6)254-60. 10.1016/j.cyto.2007.01.003
Weir T.L., Trikha S.R.J., & Thompson H.J. (2021). Diet and cancer risk reduction: The role of diet-microbiota interactions and microbial metabolites. Semin Cancer Biol, 70, 53-60. 10.1016/j.semcancer.2020.06.007.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rafaela da Mata Oliveira; Priscila Capelari Orsolin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
